Johnson & Johnson Launches ACUVUE OASYS MAX 1-Day: First Daily Disposable Contact Lens with 55% Blue Light Filtering and TearStable Technology

Nov 27, 2024 10:46 CST Updated 10:46

Johnson & Johnson

Medical Device R&D and Manufacturer

Source: Eye Future; Editor: Sophia

Reprint requirements: Can be reprinted 24 hours after the first publication, source must be credited.

Global Ophthalmology Conference Registration

Award Registration! Global Ophthalmology Innovation Series Awards

Recently,Johnson & Johnson (NYSE: JNJ)Will be showcased at the 2024 Optometry Conference.ACUVUE® Brand Contact Lenses – Newly Launched Daily DisposableACUVUE OASYS MAX (OcuComfort® MAX)A number of data, these data coverContrast Sensitivity, Brightness of Natural Images, Lens Processingand other aspects.

Johnson & Johnson will also provide data using digital technologies such as machine learning to identify potential eye diseases, as well as new insights into health economics and market access.

ACUVUE® OASYS MAX 1-Day is a product under Johnson & Johnson.New Generation Silicone Hydrogel Contact Lenses, equipped withOptiBlue Anti-Blue Light and TearStable High Moisture Retention Technology, which can simultaneously balance the two advantages of visual clarity and eye comfort. The product has been approved by the FDA and CE, andApproved by NMPA for entry into China in February 2024。

According to data from Johnson & Johnson, adults now spend an average of about 13 hours a day in front of digital devices, marking a 35% increase since 2019. Young contact lens wearers now also spend approximately 9 hours a day staring at screens.Prolonged focus can reduce blink rates by 60%, which ultimately disrupts the tear film that lubricates the eyes, leading to dryness and discomfort.。

In a survey by Johnson & Johnson, 71% of eye care professionals reported that patients complained about increased screen time, leading to tension and fatigue.75% of patients said they hoped the contact lenses would be more comfortable。

# ACUVUE OASYS MAX 1-Day

Acuvue Oasys Max 1-Day is made from senofilcon A silicone hydrogel, with a water content of 38%, and contains the internal wetting agent polyvinylpyrrolidone. This contact lensSpherical and multifocal versions，Suitable for people who use screens for long periods of time。

This isThe World's FirstContact lenses equipped with TearStable™ technology and OptiBlue™ light filter。

TearStable™ High Moisture Technology for Tear Film Stability: Adopting advanced production technology, the moisturizing factors that simulate the composition of natural tears can be evenly distributed inside and on the surface of the lens, enhancing tear film stability and achieving a lasting, hydrating, and comfortable effect.Compared to Alcon's DAILIES Total1®, CooperVision's MyDay®, and Bausch + Lomb's INFUSE®, it reduces tear evaporation rate by 2 times.。

OptiBlue™ Optical Filter：Effectively filters 55% of high-energy visible light —— blue-violet light, reducing light scattering, making vision more durable, clear, and comfortable. ACUVUE® OASYS MAX 1-Day reduces light scattering by 20%, halos by 30%, and glare by 23% compared to ACUVUE® OASYS 1-Day.

# Advantages in Appearance and Operational Performance

Unique Blue-Green AppearanceThe blue-green appearance of ACUVUE OASYS MAX 1-Day contact lenses is the result of the combination of the blue-violet light filter in OptiBlue technology and an additional blue treatment tint.

This color design not only helps protect the eyes from blue light damage but also enhances the visibility of the lenses.。

Moreover, presbyopia patients often face challenges when observing and handling small objects up close, including the insertion and removal of contact lenses. The high visibility design of ACUVUE OASYS MAX 1-Day makes it easier for these patients to handle their contact lenses.

Improve Lens Visibility: According to consumer research,The blue-green appearance of ACUVUE OASYS MAX 1-Day makes the lens more visible in the blister pack., which is a significant advantage for users who may have difficulty seeing through transparent or light-colored lenses.

Better Operability: Compared with Dailys Total1, ACUVUE OASYS MAX 1-Day contact lenses perform better in terms of operability. This study involved 98 consumers who are habitual contact lens wearers, and the results showed,The unique blue-green appearance makes ACUVUE OASYS MAX 1-Day more convenient to handle.。

# Upcoming Trial Results

Evaluation of the Impact of Multifocal Contact Lenses with HEV (High-Energy Visible Light) Filtering Technology on Halos and Light Scattering。HEV filtration technology is designed to reduce high-energy visible light that is harmful to the eyes, particularly blue light.This technology can reduce the risk of light damage, but it may also affect visual quality, including contrast sensitivity and halos.
In a study targeting35 NamesIn the clinical trial of subjects, the possibility of filtering HEV light to reduce halos and light scattering was evaluated.

Evaluation of Myopia Control Effects，A Comprehensive Model Predicts the Effectiveness of Myopia Control Interventions and Provides Reference Data Based on One Year of Data。
Axial length (AL) and spherical equivalent (SE) are key indicators for predicting myopia progression.The increase in axial length is closely related to the development of myopia, especially within a few years before and after the onset of myopia in children, during which the axial growth is more significant.Changes in refraction are also an important parameter for monitoring the progression of myopia, especially in children and adolescents, where rapid changes in refraction often indicate the rapid development of myopia.

# About Johnson & Johnson Vision

Johnson & Johnson Vision, a subsidiary of Johnson & Johnson, is dedicated to eye health and includesOphthalmic implants, surgical medical devices and consumables included in the "Advanced Vision" businessAnd"Vision Care" Business of Contact Lenses, Contact Lens Care Solutions, and Eye Drops。

In 2016, Johnson & Johnson acquired Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott, for $4.3 billion, obtaining ophthalmic products related to cataract surgery, laser refractive surgery, and consumer eye health, forming its current Vision business.Products under 眼力健 include those used for cataract and presbyopia correction surgeries.The new generation of continuous vision intraocular lenses, and the Catalys femtosecond laser ophthalmic treatment system, etc.。

Johnson & Johnson Vision Care evolved from Frontier Contact Lenses, a company established in 1959 and acquired by Johnson & Johnson in 1981. Vision Care owns globally renowned...Contact Lens Brand ACUVUEIn 1993, Johnson & Johnson launched the world's first daily disposable contact lens, followed by products such as colored contact lenses.

The Third Quarter of 2024,Company Vision Surgical Revenue $333 Million, an increase of 1.3% from US$328 million in the third quarter of 2023.AllThe sales of spherical contact lenses amounted to 968 million US dollars., an increase of 4.2% from US$928 million in the third quarter of 2023,Thanks to the continued strong performance of ACUVUE OASYS 1-Day daily disposable contact lenses, including the newly launched OASYS MAX 1-Day.

Johnson & Johnson's Total Revenue in the Third Quarter of 2024 was $22.5 Billion, a 5.2% Increase from $21.4 Billion in the Third Quarter of 2023.

# Global Leading Ophthalmic Device and Consumables Company

# Chinese Ophthalmic Devices and Consumables Companies

# China Ophthalmology Medical Service Company

# Overseas Ophthalmology Startups